OTC ROGAINE ACTUAL-USE STUDY SUGGESTED
This article was originally published in The Tan Sheet
Executive Summary
OTC ROGAINE ACTUAL-USE STUDY SUGGESTED by Nonprescription Drugs Advisory Committee Chair Randy Juhl, PhD, University of Pittsburgh, as a way for Upjohn to demonstrate that proposed labeling addresses the concerns raised during the advisory committee's July 27 review of the Rx-to-OTC switch application. "I think [the committee] could really benefit by having a use study" looking at the effectiveness of Rogaine's OTC labeling, Juhl suggested.